Innovative mental health medicines for patients with unmet needs.
KRN-101
PTSD and Anxiety drives healthcare costs, lost workdays, and devastating human suffering.
NEURO NATURE Labs
Evidence‑based natural anxiolytics deliver safer, effective treatments for anxiety.
NEUROPATH AI CARE
AI accelerates diagnosis, monitors for crises, and personalizes mental healthcare.
The Science & Strategy:
Dr. Malcolm Barratt-Johnson, Chief Medical Officer
Natural Medicines with Psychotherapy
Our Opportunity
Albert Labs is pioneering regulated psychedelic‑assisted therapies for complex anxiety and PTSD. We leverage natural bioactives to enhance psychotherapy, addressing significant unmet needs in global mental health through a focused pipeline, disciplined development, and a real‑world clinical strategy designed to accelerate validation and value creation.
Our Pathway
Our proprietary Real‑World Evidence (RWE) framework enables faster market access while generating regulator and payer‑grade data. By integrating clinical practice with GLP‑certified science, Albert Labs reduces development risk, builds early adoption, and establishes a scalable route to commercialization in high‑burden anxiety indications.
Our Science
Our lead assets—KRN‑101, a psilocybin‑derived natural medicine, and a D8CBN are both adjunct medicines to Psychotherapy—are advanced under GLP standards and precision bioprocessing. Each targets complex anxiety disorders, including PTSD and cancer‑related anxiety, delivering reproducible quality, and clear regulatory alignment, in natural‑bioactive‑based mental health therapeutics.
KRN 101
Psilocybin modulates key serotonin pathways to reduce depressive symptoms, ease complex anxiety, and unlock therapeutic breakthroughs for PTSD. Clinical studies highlight its potential as an adjunct in psychotherapy, delivering durable improvements where conventional treatments often fall short. This positions psilocybin as a transformative, evidence-based solution at the forefront of mental health innovation.
D8CBN
Delta-8/CBN engages the endocannabinoid system to ease anxiety, stabilize mood, and support therapeutic outcomes. Early evidence suggests its potential as an adjunct in psychotherapy, enhancing treatment response where conventional options fall short. Albert Labs’ intellectual property protects this breakthrough approach, positioning Delta-8/CBN as a novel, evidence-based mental health solution.
Neuro Nature Labs
Elevating Traditional Herbal Supplements to Global Regulatory Standards
For thousands of years natural remedies have delivered healing across cultures. Neuronature Labs transforms these traditions through GLP-certified laboratories, ensuring safety, efficacy, and data quality at the highest global standard.
With every protocol aligned to FDA, Health Canada, and EFSA’s Novel Foods standards, our therapies meet the same regulatory level as pharmaceuticals — yet with the superior safety profile of time-tested natural products. Our focus is on conditions like anxiety and treatment-resistant mental health challenges, where conventional drugs often fall short.
The $400+ billion nutraceutical market already surpasses many pharmaceutical segments, creating an enormous opportunity to bring rigorously validated, patient-first natural medicines to those in need.
Find Mindful Clarity
Get Nature’s Tranquility
Enhance Your Sleep Quality
Rediscover Intimate Passion
NeuroPath AI Care
At NeuroPath AI, we believe the future of mental health care is precise, personal, and powered by technology. Our AI platform brings together multiple data streams to understand anxiety in real time.
From behavioral patterns to physiological biomarkers, every element is captured, analyzed, and translated into a validated mental health score.
This score guides recommendations for natural, science-backed treatments — offering patients pathways to relief where traditional pharmaceuticals often fall short.
